![Mark Newman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Newman
Teknisk/Vetenskaplig/F&U Direktör på
GEOVAX LABS
Förmögenhet: - $ per 2026-10-31
Profil
Mark J.
Newman is the founder of Newmark Diagnostics LLC, founded in 2016.
Dr. Newman is currently Chief Scientific Officer at GeoVax Labs, Inc., a position held since 2020.
Former positions include Vice President-Research & Development at Epimmune, Inc. in 2005, Vice President-Research & Development at Emergent Travel Health, Inc. in 2009, Vice President-Research & Development at Pharmexa A in 2008, Vice President-Infectious Diseases at IDM Pharma, Inc. in 2011, and Vice President-Research & Development at GeoVax Labs, Inc. from 2010 to 2013.
Dr. Newman was also a Member at Louisiana State University.
Education includes undergraduate and graduate degrees from The Ohio State University and a doctorate from John Curtin School of Medical Research.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
GEOVAX LABS, INC. -.--% | 2026-08-28 | 0 ( -.--% ) | - $ | 2026-10-31 |
Aktiva positioner av Mark Newman
| Företag | Position | Start |
|---|---|---|
| GEOVAX LABS | Teknisk/Vetenskaplig/F&U Direktör | 2020-08-25 |
Tidigare kända positioner av Mark Newman
| Företag | Position | Slut |
|---|---|---|
| GEOVAX LABS | Teknisk/Vetenskaplig/F&U Direktör | 2013-01-01 |
IDM Pharma, Inc.
 IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Företagsledare/Principal | 2011-04-28 |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Teknisk/Vetenskaplig/F&U Direktör | 2009-12-01 |
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Teknisk/Vetenskaplig/F&U Direktör | 2008-12-01 |
Epimmune, Inc.
 Epimmune, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to treat and prevent infectious diseases and cancer | Teknisk/Vetenskaplig/F&U Direktör | 2005-12-01 |
Mark Newmans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
29
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Epimmune, Inc.
Epimmune, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to treat and prevent infectious diseases and cancer | Health Technology |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Health Technology |
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Louisiana State University
 Louisiana State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDM Pharma, Inc.
IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Health Technology |
GeoVax Labs, Inc.
 GeoVax Labs, Inc. BiotechnologyHealth Technology Develops vaccines for diseases caused by Human Immunodeficiency Virus and other infectious agents | Health Technology |
Newmark Diagnostics LLC | |
John Curtin School of Medical Research
 John Curtin School of Medical Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
